WIA
SLS icon

World Investment Advisors’s SELLAS Life Sciences SLS Stock Holding History

World Investment Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Sell
24,616
-19,507
-44% -$87.3K ﹤0.01% 1527
2025
Q4 		$166K Buy
+44,123
New +$85.8K ﹤0.01% 1411

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

World Investment Advisors's SLS Position: Q1 2026 in Review

World Investment Advisors reduced its SELLAS Life Sciences (SLS) stake by 44% in Q1 2026, selling an estimated $87.3K and leaving 24,616 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

World Investment Advisors first reported a position in SLS in Q4 2025 and has held it in 2 quarters since. The position peaked at $166K in Q4 2025. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • World Investment Advisors held 24,616 shares of SELLAS Life Sciences worth $104K as of Q1 2026.
  • World Investment Advisors sold 19,507 SELLAS Life Sciences shares in Q1 2026, an estimated $87.3K.
  • SELLAS Life Sciences made up ﹤0.01% of World Investment Advisors's portfolio in Q1 2026, its #1527 holding.
  • World Investment Advisors first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • World Investment Advisors's SELLAS Life Sciences position peaked at $166K in Q4 2025.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on World Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.